Research/art/teacher profile of a person
Name and surname:
prof. PharmDr. Adriana Duriš Adameová, DrSc.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Duriš Adameová
I.2 - Name
Adriana
I.3 - Degrees
prof. PharmDr., PhD., FIACS
I.4 - Year of birth
1978
I.5 - Name of the workplace
Faculty of Pharmacy, Comenius University in Bratislava
I.6 - Address of the workplace
Odbojárov 10, Bratislava, 832 32
I.7 - Position
full professor
I.8 - E-mail address
adameova@fpharm.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3686
I.10 - Name of the study field in which a person works at the university
pharmacology
I.11 - ORCID iD
https://orcid.org/ 0000-0002-9803-043X

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University in Bratislava
II.b - Year
2002
II.c - Study field and programme
farmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University in Bratislava,
II.b - Year
2006
II.c - Study field and programme
pharmacology
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University in Bratislava,
II.b - Year
2014
II.c - Study field and programme
pharmacology
II.5 - Professor
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University in Bratislava,
II.b - Year
2018
II.c - Study field and programme
pharmacology
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
full professor Faculty of Pharmacy, Comenius University in Bratislava, 2018-
associate professor Faculty of Pharmacy, Comenius University in Bratislava, 2015-2017
assistant professor Faculty of Pharmacy, Comenius University in Bratislava, 2005-2014
visiting scientist Institute of Cardiovascular Sciences, St. Boniface Research Centre, Winnipeg, Canada 2007
visiting scientist College of Pharmacy, University of Michigan, Ann Arbor 2023

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
rozvoj laboratórnych techník The Hatter Cardiovascular Institute, University College London, UK 2007
letná škola, rozvoj vedeckých činností ESC Summer School, Nice, France 2009

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
pharmacology pharmacy 2. pharmacy
pharmacology pharmacy 1. and 2 combined
pharmacology pharmacology 3.
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
pharmacology Pharmacology - PhD pharmacy
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a - Name of the field of habilitation procedure and inaugural procedure V.3.b - Study field to which it is assigned
pharmacology
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
2
V.4.c - Dissertation (third degree)
1
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
>30
V.4.c - Dissertation (third degree)
4
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
> 320 (university library record)
VI.1.b - Over the last six years
80 (university library record)
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
93 (Scopus)
VI.1.b - Over the last six years
26(Scopus)
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
> 1800 (Scopus)
VI.1.b - Over the last six years
> 1300 (Scopus)
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
> 1800 (Scopus)
VI.1.b - Over the last six years
>1300 (Scopus)
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
5
VI.1.b - Over the last six years
1
VI.2 - The most significant research/artistic/other outputs
1

Adameova A, Goncalvesova E, Szobi A, Dhalla NS.

Necroptotic cell death in failing heart: relevance and proposed mechanisms

Heart Fail Rev. 2016 Mar;21(2):213-21. 

2

Szobi A, Gonçalvesová E, Varga ZV, Leszek P, Kuśmierczyk M, Hulman M, Kyselovič J, Ferdinandy P, Adameová A.

Analysis of necroptotic proteins in failing human hearts.

J Transl Med. 2017 Apr 28;15(1):86.

3

Adameova A, Hrdlicka J, Szobi A, Farkasova V, Kopaskova K, Murarikova M, Neckar J, Kolar F, Ravingerova T, Dhalla NS.

Evidence of necroptosis in hearts subjected to various forms of ischemic insults.

Can J Physiol Pharmacol. 2017 Oct;95(10):1163-1169.

4

Lichý M, Szobi A, Hrdlička J, Horváth C, Kormanová V, Rajtík T, Neckář J, Kolář F, Adameová A.

Different signalling in infarcted and non-infarcted areas of rat failing hearts: A role of necroptosis and inflammation.

J Cell Mol Med. 2019 Sep;23(9):6429-6441.

5


Adameova A, Abdellatif Y, Dhalla NS.

Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease.

Can J Physiol Pharmacol. 2009 Jul;87(7):493-514. 

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Jarabicová I, Horváth C, Chudý M, Goncalvesová E, Adameová A. Analysis of the serum levels of RIP3 and Drp1 in patients with heart failure. ESC Heart Fail. 2024 Mar 21.

2

Jarabicová I, Horváth C, Veľasová E, Bies Piváčková L, Vetešková J, Klimas J, Křenek P, Adameova A,

Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension.

J Cell Mol Med. 2022 May;26(9):2633-2645

3

Davidson SM, Adameová A, Barile L, Cabrera-Fuentes HA, Lazou A, Pagliaro P, Stensløkken KO, Garcia-Dorado D;

Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury.

J Cell Mol Med. 2020 Apr;24(7):3795-3806. 

4

Mishra PK, Adameova A, Hill JA, Baines CP, Kang PM, Downey JM, Narula J, Takahashi M, Abbate A, Piristine HC, Kar S, Su S, Higa JK, Kawasaki NK, Matsui T.

Guidelines for evaluating myocardial cell death.

Am J Physiol Heart Circ Physiol. 2019 Nov 1;317(5):H891-H922.

5

Horvath C, Jarabicova I, Kura B, Kalocayova B, Faurobert E, Davidson SM, Adameova A.

Novel, non-conventional pathways of necroptosis in the heart and other organs: Molecular mechanisms, regulation and inter-organelle interplay.

Biochim Biophys Acta Mol Cell Res. 2023 Oct;1870(7):119534. 

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Heusch, G. Myocardial ischaemia–reperfusion injury and cardioprotection in perspective. Nature Reviews Cardiology 2020, 17(12), pp. 773-789



2

Liu, Y., Zeng, L., Yang, Y., (...), Wang, D., Wang, H. cyl-CoA thioesterase 1 prevents cardiomyocytes from Doxorubicin-induced ferroptosis via shaping the lipid composition. Cell Death and Disease, 2020, 11(9),756

3

Mao, S., Chen, P., Pan, W., Gao, L., Zhang, M. Exacerbated post-infarct pathological myocardial remodelling in diabetes is associated with impaired autophagy and aggravated NLRP3 inflammasome activation. ESC Heart Failure, 2021

4

Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Wang, J., Deng, B., Liu, Q., (...), Xian, S., Wang, L.. Cell Death and Disease, 2020, 11(7),574

5

Yadav, S.K., Gawargi, F.I., Hasan, M.H., (...), Upton, J.W., Mishra, P.K.Differential effects of CMV infection on the viability of cardiac cells. Cell Death Discovery 2023, 9(1),111

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

RECOVERY AND RESILIENCE PLAN OF THE SR FROM THE CHALLENGE - Scholarships for excellent researchers R4, 09I03-03-V04-00231/2024/VA, Understanding necroptosis and pyroptosis for the treatment and diagnosis of cardiovascular diseases, 2024-2026, €213,030.72, principal investigator

2

Necroptotic and pleiotropic effects of RIP3 kinase acting as a convergent point in cardiac cell loss: understanding the basic mechanisms in the ischemic heart with or without metabolic stress as a tool for designing therapeutic approaches. APVV (APVV-20-0242), 2021-2025, 220 000€, PI

3

Extracellular Vesicle Research Exchanges for Advanced Biomarkers and Therapeutics, HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA), HORIZON-MSCA-2023-SE-01-01, Grant agreement ID: 101183034, 2025-2028, 27,600 €, partner, principal investigator for the Slovak Republic

4

Commercial & Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular & CNS Dysfunction, Cancer and Cardiovascular Disease, H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme, MSCA-RISE-2020 - Research and Innovation Staff Exchange, Grant agreement ID: 101007931, 2020-2024, 2026600 €, partner, principal investigator for the Slovak Republic

5

ERANET grant, Horizont 2020, Network of European funding for neuroscience research – Calcium channels and cell death in cerebral malformations, 2023-2026, 120 000€, Partner, rosposnisle person for a project done in Sloakia

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Chair of the organizing committee of the international conference with the participation of approximately 170 delegates 10th Annual Meeting of the European Section of the International Academy of Cardiovascular Sciences 28-30/10/2024

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Institute of Cardiovascular Sciences, St. Boniface Research Centre, Winnipeg, Kanada 351 Tache Ave, Winnipeg, MB R2H 2A6, Kanada 2007 visiting scientist
The Hatter Cardiovascular Institute, University College Londýn, UK 67 Chenies Mews, London WC1E 6HX, Spojené kráľovstvo 2007 - 1 month training in laboratory techniques
College of Pharmacy, University of Michigan, USA 428 Church St, Ann Arbor, MI 48109, 2023 - 6 weeks visiting researcher/professor

IX. - Other relevant facts